A drug with the SMILES c1ccc2c(c1)[nH]c1nc(SCCN3CCOCC3)nnc12 has a human ether-à-go-go related gene (hERG) inhibition at 1uM of 5.284\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
c1ccc2c(c1)[nH]c1nc(SCCN3CCOCC3)nnc12
c1ccc2c(c1)[nH]c1nc(SCCN3CCOCC3)nnc12
4-[2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylsulfanyl)ethyl]morpholine